Toggle light / dark theme

Hallucinogens, neuro-immunology and the microbiome — convergent approaches in mental healthcare — mike wang, johns hopkins university.


Mike Wang, is a neuro-psychiatric researcher and adjunct teaching faculty in neuroscience at the Johns Hopkins Krieger School of Arts and Sciences.

Mike is one of the youngest principal investigators at the Johns Hopkins School of Medicine and currently leads a clinical trial examining how hallucinogenic levels of over-the-counter dextromethorphan might serve as the world’s first rapid acting oral antidepressant. (Those interested in the clinical trial for dextromethorphan can.

Although the definitive causes of Alzheimer’s diseases aren’t yet fully understood, one of the leading suspects is the accumulation of abnormal proteins in the brain that impinges on the activity of the neurons. Scientists at Northwestern University have explored this phenomenon in a group of elderly individuals with excellent memory, known as SuperAgers, and found them to be far more resistant to the troublesome buildup of some of these proteins, shedding further light on how the disease may take hold.

A lot of the research into the progression of Alzheimer’s focus on a pair of proteins called amyloid and tau. Clumps of amyloid are thought to build up and develop into plaques that impact on memory and cognitive function, while tau takes the form of tangles that interfere with the way nutrients are taken up by the neurons, eventually leading to the death of the cell.

The Northwestern University researchers carried out experiments to study the prevalence of these proteins in SuperAgers, a group of subjects over the age of 80 with the memory capacity of someone 20 to 30 years younger than them. These subjects are assessed annually as part of ongoing research at Northwestern’s Mesulam Center for Cognitive Neurology and Alzheimer’s Disease.

Dwight E. Bergles, Ph.D., a leading neuroscientist at Johns Hopkins University School of Medicine, is the winner of the prestigious Barancik Prize for Innovation in MS Research. Bergles has pioneered the study of immature cells in the brain that can regenerate myelin-making cells after myelin is destroyed in MS. These cells, oligodendrocyte precursor cells (OPCs), hold the key to finding ways to promote myelin repair and restore function for people living with multiple sclerosis.

This is the FIRST part of the interview with Rodolfo Goya.


In this video Professor Goya talks about his role in the original experiment and the progress in his current study to reproduce the results with young blood plasma.

Professor Rodolfo Goya is Senior Scientist at The National Scientific and Technical Research Council in Argentina where he is a biochemist and researcher.

A study from the University of Wisconsin-Madison published on September 14 in Science revealed that when a plant is injured, they release a nervous system-like signal throughout their body, similar to the pain response found in humans and other animals.

When a human is injured, sensory cells in our bodies alert our nervous system to release the neurotransmitter glutamate. This stimulates a part of our brain to release adrenaline, which kicks our fight-or-flight response into gear. Plants don’t have nervous systems but video captured by the scientists behind this new study of injured plants shows that they do have their own version of fight-or-flight when they come under attack.

The footage captured by the study’s scientists shows a caterpillar eating away at a plant and the plant’s subsequent response. Because they lack a nervous system, plants don’t have neurotransmitters, but they do still have glutamate. In the video, a plant is bitten by a caterpillar and releases glutamate at the bite site. This activates a calcium wave to rush through the plant’s entire body, which then triggers the plant to release their own stress hormone.